Associations between interleukin-1 gene polymorphisms and sepsis risk: A meta-analysis

BMC Medical Genetics

Volumn 15, Issue 1, 2014, Pages

  Zhang, An qiang ^a   Pan, Wei ^a   Gao, Jun wei ^a   Yue, Cai li ^a   Zeng, Ling ^a   Gu, Wei ^a   Jiang, Jian xin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

IL 1; Meta analysis; Polymorphism; Sepsis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ARTICLE; CAUCASIAN; DISEASE SEVERITY; ETHNICITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; POLYMORPHISM, GENETIC; SEPSIS;

EID: 84892398184     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-15-8     Document Type: Article

References (44)

1. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008, 8(10):776-787.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
3. Grealy R, White M, Stordeur P, Kelleher D, Doherty DG, McManus R, Ryan T. Characterising cytokine gene expression signatures in patients with severe sepsis. Mediators Inflamm 2013, 2013:164246.
4. Wen AQ, Gu W, Zeng L, Zhou J, Jiang DP, Zhang L, Du DY, Hu P, Chen K, Liu Q, Wang ZG, Jiang JX. Clinical relevance of IL-1beta promoter polymorphisms (-1470, -511, and -31) in patients with Chinese major trauma patients. Shock 2010, 33(6):576-582.
5. Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007, 2007:31397.
6. Fida NM, Al-Mughales J, Farouq M. Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr Int 2006, 48(2):118-124.
7. Pruitt JH, Copeland EM, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 1995, 3(4):235-251.
8. Opal SM, Fisher CJ, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med 1997, 25(7):1115-1124.
9. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87(6):2095-2147.
10. Vamvakopoulos JE, Taylor CJ, Morris-Stiff GJ, Green C, Metcalfe S. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 2002, 29(4):337-340.
11. Zapata-Tarres M, Arredondo-Garcia JL, Rivera-Luna R, Klunder-Klunder M, Mancilla-Ramirez J, Sanchez-Urbina R, Vazquez-Cruz MY, Juarez-Villegas LE, Palomo-Colli MA. Interleukin-1 receptor antagonist gene polymorphism increases susceptibility to septic shock in children with acute lymphoblastic leukemia. Pediatr Infect Dis J 2013, 32(2):136-139.
12. Wan QQ, Ye QF, Ma Y, Zhou JD. Genetic association of interleukin-1(beta) (-511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients. Transplant Proc 2012, 44(10):3026-3028.
13. Johnson MD, Plantinga TS, Van De Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LAB, Van Der Meer JWM, Van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG. Cytokine gene polymorphisms and the outcome of invasive candidiasis: A prospective cohort study. Clin Infect Dis 2012, 54(4):502-510.
14. Shimada T, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada T-A, Tateishi Y, Otani S, Hirasawa H, Tokuhisa T, Uno H. Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population. Cytokine 2011, 54(1):79-84.
15. Gu W, Zeng L, Zhou J, Jiang DP, Zhang L, Du DY, Hu P, Chen K, Liu Q, Wang ZG, Jiang JX. Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Med 2010, 36(7):1261-1265.
16. Emonts M, Vermont CL, Houwing-Duistermaat JJ, Haralambous E, Gaast-de Jongh CE, Hazelzet JA, Faust SN, Betts H, Hermans PWM, Levin M, de Groot R. St Mary's Imperial Coll G, Erasmus MCSCsH Polymorphisms in parp, Il1b, Il4, Il10, C1inh, Defb1, and Defa4 in meningococcal disease in three populations. Shock 2010, 34(1):17-22. St Mary's Imperial Coll G, Erasmus MCSCsH.
17. Davis SM, Clark EA, Nelson LT, Silver RM. The association of innate immune response gene polymorphisms and puerperal group a streptococcal sepsis. Am J Obstet Gynecol 2010, 202(3):e301-308.
18. Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Nakatsu T, Saito H, Minamiya Y, Murata K, Suzuki T, Ogawa J. Interferon-gamma 874A > T genetic polymorphism is associated with infectious complications following surgery in patients with thoracic esophageal cancer. Surgery 2009, 146(5):931-938.
19. Garcia-Segarra G, Espinosa G, Tassies D, Oriola J, Aibar J, Bove A, Castro P, Reverter J-C, Nicolas J-M. Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med 2007, 33(8):1354-1362.
20. Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol 2005, 11(28):4409-4413.
21. Bessler H, Osovsky M, Sirota L. Association between IL-1ra gene polymorphism and premature delivery. Biol Neonate 2004, 85(3):179-183.
22. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004, 41(11):808-813.
23. Treszl A, Kocsis I, Szathmari M, Schuler A, Heninger E, Tulassay T, Vasarhelyi B. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003, 83(4):241-245.
24. Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?. Genes Immun 2003, 4(8):533-540.
25. Ma P, Chen D, Pan J, Du B. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002, 30(5):1046-1050.
26. Arnalich F, Lopez-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM, Capiscol C, Fernandez-Capitan C, Madero R, Montiel C. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002, 127(2):331-336.
27. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999, 27(7):1330-1334.
28. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2011, Ottawa Health Research Institute, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 20 October 2011.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
30. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004, 57(7):683-697.
31. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000, 320(7249):1574-1577.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
33. Noble WS. How does multiple testing correction work?. Nat Biotechnol 2009, 27(12):1135-1137.
34. Watanabe E, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Abe R, Nakada T. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005, 59(5):1181-1189. discussion 1189-1190.
35. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000, 79(11):1864-1869.
36. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22(6):396-402.
37. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34(2):204-209.
38. Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, Leong SS, Lim E, Lim TK, Ng AW, Poh WT, Tee A, Teh M, Salim A, Seow A. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 2011, 32(4):522-529.
39. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006, 15(4):519-529.
40. Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX. Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock 2006, 26(1):25-30.
41. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998, 47(3):195-198.
42. Weber A, Wasiliew P, Kracht M. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal 2010, 3(105):cm2.
43. Watanabe E, Buchman TG, Hirasawa H, Zehnbauer BA. Association between lymphotoxin-(alpha) (tumor necrosis factor-(beta)) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med 2010, 38(1):181-193.
44. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.